-
Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
EORTC Quality of Life Group and EORTC Brain Tumor Group, Nov 2022, In: Quality of life research. 31, 11, p. 3253-3266 14 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101
Caramanna, I., de Kort, J. M., Brandes, A. A., Taal, W., Platten, M., Idbaih, A., Frenel, J. S., Wick, W., Preetha, C. J., Bendszus, M., Vollmuth, P., Reijneveld, J. C. & Klein, M., 1 Aug 2022, In: Neuro-oncology practice. 9, 4, p. 310-316 7 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials
EORTC Quality of Life Group and Brain Tumour Group, Feb 2021, In: European Journal of Cancer. 144, p. 162-168 7 p.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
